Search details
1.
The yin and yang functions of extracellular ATP and adenosine in tumor immunity.
Cancer Cell Int
; 20: 110, 2020.
Article
in English
| MEDLINE | ID: mdl-32280302
2.
Zanubrutinib, rituximab and lenalidomide induces deep and durable remission in TP53-mutated B-cell prolymphocytic leukemia: a case report and literature review.
Haematologica
; 107(5): 1226-1228, 2022 05 01.
Article
in English
| MEDLINE | ID: mdl-34937321
3.
Epigenetic regulation of CD38/CD48 by KDM6A mediates NK cell response in multiple myeloma.
Nat Commun
; 15(1): 1367, 2024 Feb 14.
Article
in English
| MEDLINE | ID: mdl-38355622
4.
Assessment of antibacterial properties and the active ingredient of plant extracts and its effect on the performance of crucian carp (Carassius auratus gibelio var. E'erqisi, Bloch).
J Sci Food Agric
; 93(4): 902-9, 2013 Mar 15.
Article
in English
| MEDLINE | ID: mdl-22903651
5.
Targeting BCMA in Multiple Myeloma: Advances in Antibody-Drug Conjugate Therapy.
Cancers (Basel)
; 15(8)2023 Apr 11.
Article
in English
| MEDLINE | ID: mdl-37190168
6.
Simultaneous determination of triazole fungicides in animal-origin food by ultra-high-performance liquid chromatography coupled with tandem mass spectrometry.
Food Chem X
; 20: 100956, 2023 Dec 30.
Article
in English
| MEDLINE | ID: mdl-38144806
7.
Case report: Successful management of a refractory double-expressor diffuse large B-cell lymphoma patient under the guidance of in vitro high-throughput drug sensitivity test.
Front Oncol
; 12: 1079890, 2022.
Article
in English
| MEDLINE | ID: mdl-36741708
8.
Improving the Quality of Frozen Lamb by Microencapsulated Apple Polyphenols: Effects on Cathepsin Activity, Texture, and Protein Oxidation Stability.
Foods
; 11(4)2022 Feb 14.
Article
in English
| MEDLINE | ID: mdl-35206014
9.
γ-secretase inhibitors augment efficacy of BCMA-targeting bispecific antibodies against multiple myeloma cells without impairing T-cell activation and differentiation.
Blood Cancer J
; 12(8): 118, 2022 08 16.
Article
in English
| MEDLINE | ID: mdl-35973981
10.
Promising Antigens for the New Frontier of Targeted Immunotherapy in Multiple Myeloma.
Cancers (Basel)
; 13(23)2021 Dec 06.
Article
in English
| MEDLINE | ID: mdl-34885245
11.
Preclinical evaluation of CD8+ anti-BCMA mRNA CAR T cells for treatment of multiple myeloma.
Leukemia
; 35(3): 752-763, 2021 03.
Article
in English
| MEDLINE | ID: mdl-32632095
12.
ERK signaling mediates resistance to immunomodulatory drugs in the bone marrow microenvironment.
Sci Adv
; 7(23)2021 06.
Article
in English
| MEDLINE | ID: mdl-34088671
13.
BCMA-Specific ADC MEDI2228 and Daratumumab Induce Synergistic Myeloma Cytotoxicity via IFN-Driven Immune Responses and Enhanced CD38 Expression.
Clin Cancer Res
; 27(19): 5376-5388, 2021 10 01.
Article
in English
| MEDLINE | ID: mdl-34301753
14.
Determination of five Alternaria toxins in wolfberry using modified QuEChERS and ultra-high performance liquid chromatography-tandem mass spectrometry.
Food Chem
; 311: 125975, 2020 May 01.
Article
in English
| MEDLINE | ID: mdl-31855777
15.
BCMA-Targeting Therapy: Driving a New Era of Immunotherapy in Multiple Myeloma.
Cancers (Basel)
; 12(6)2020 Jun 05.
Article
in English
| MEDLINE | ID: mdl-32516895
16.
The immunomodulatory drugs lenalidomide and pomalidomide enhance the potency of AMG 701 in multiple myeloma preclinical models.
Blood Adv
; 4(17): 4195-4207, 2020 09 08.
Article
in English
| MEDLINE | ID: mdl-32898244
17.
A novel BCMA PBD-ADC with ATM/ATR/WEE1 inhibitors or bortezomib induce synergistic lethality in multiple myeloma.
Leukemia
; 34(8): 2150-2162, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32060401
18.
VIS832, a novel CD138-targeting monoclonal antibody, potently induces killing of human multiple myeloma and further synergizes with IMiDs or bortezomib in vitro and in vivo.
Blood Cancer J
; 10(11): 110, 2020 11 02.
Article
in English
| MEDLINE | ID: mdl-33149123
19.
APRIL signaling via TACI mediates immunosuppression by T regulatory cells in multiple myeloma: therapeutic implications.
Leukemia
; 33(2): 426-438, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30135465
20.
A genome-scale CRISPR-Cas9 screening in myeloma cells identifies regulators of immunomodulatory drug sensitivity.
Leukemia
; 33(1): 171-180, 2019 01.
Article
in English
| MEDLINE | ID: mdl-30026574